[ET Net News Agency, 17 March 2025] REMEGEN (09995) rose 10.2% to HK$17.86, breaking
above the 20-D SMA of HK$16.855.
It hits an intra-day high of HK$17.86, and an intra-day low of HK$16.18. The total
shares traded was 3.39 million, with a value of HK$58.56m. The active buy/sell ratio is
68:32, with net buying turnover of HK$20.04m. CHINA INNOVATION MARKET SER accounts for
greatest net responsive buying turnover of HK$4.15m, with volume weighted average price of
HK$17.24. CHINA INV INFO accounts for greatest net responsive selling turnover of
HK$9.44m, with volume weighted average price of HK$17.32. The stock has risen a combined
13.9% over the past 2 consecutive trading days.

Basic Information
=================

----------------------------------
Nominal 17.860 % Chg +10.25%
High 17.860 Low 16.180
Shares Tr 3.39m Turnover 58.56m
10-D SMA 16.812 %H.V 70.499
20-D SMA 16.855 VWAP 17.281
50-D SMA 14.845 RSI14 59.337
----------------------------------
Status: Breaking above the 20-D SMA, active buy/sell ratio is 68:32, with net buying
turnover of HK$20.04m, rising a combined 13.9% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
REMEGEN (09995) 17.86 +10.25
HUTCHMED (00013) 23.40 -3.90
GENSCRIPT BIO (01548) 12.34 -1.28
INNOVENT BIO (01801) 40.80 -0.37
EVEREST MED-B (01952) 52.75 +3.03
WUXI BIO (02269) 26.70 +0.19
WUXI APPTEC (02359) 65.10 +0.93
BEIGENE (06160) 154.60 +2.52
ZAI LAB (09688) 29.95 +2.57
AKESO (09926) 70.00 -2.78
---------------------------------------------
(ed)